Better at Predicting RA from MRI: Humans or Computers? https://t.co/xRVatfiRKS https://t.co/Gwypq8lcdl

• https://bit.ly/3N9PqFu

The future of lupus treatment is oral therapies? There has been an explosion of trials in SLE, including nonrenal and glomerulonephritis studies. @Janetbirdope https://t.co/IQ9bxbTSV4 https://t.co/jVYOphxpAE

• https://bit.ly/3MQhbSh

In an early SpA (DESIR) cohort, the occurrence of a first pregnancy did not seem to increase the number of imaging abnormalities of the SIJ. Overall no significant changes in radiographic and MRI imaging abnormalities of the SIJ, Molto A, Abst#POS0303, #EULAR2023 @RheumNow

Supervised 12 weeks High-intensity interval training program Improves Vo2 peak in IA patients But does not improve pain or fatigue It is disappointing but it is also a small study w/ n=30 pts in each group. It is unclear if the type of exercise has an impact on outcome https://t.co/Plk7sflrh5

What happens when an AI-based symptom checker & an online self-referral tool play Rheumatologists? They don't seem to do great yet! 600 new pts, outw/ 36% dvlpd IA IA Sens 62% Spe 47% Tool Sens 66% Spe 54% More work needed to implement these in practice #EULAR23 @Rheumnow

RheumNow’s expanded coverage of the #EULAR2023 meeting is sponsored in part by Bristol Myers Squibb. All content is chosen by RheumNow and its faculty.

RheumNow Eular 2023 Daily Recap Series https://t.co/ZJd3mSBcau

• https://twitter.com/i/broadcasts/1djxXlQmVZyxZ

AOSD: Young vs. Elderly Onset AOSDis an autoinflammatory condition characterized by fevers, arthritis, and rash. It is considered an orphan disease because of its low prevalence - it is reported anywhere between 16 to 40 per ten million. https://t.co/PPI1fvwLAf https://t.co/qMXMsbpwl3

• https://bit.ly/3ONeMdz

Top Influencers of #EULAR2023 👉 @eular_org @EMEUNET @RheumNow @ARD_BMJ @drdavidliew @Janetbirdope https://t.co/uUJM6tW824 via @symplur

• #EULAR2023 - eular 23 - Social Media Analytics and Transcripts